A study published in Medical Cannabis and Cannabinoids examined the treatment of diabetic peripheral neuropathy (DPN) using medical cannabis transdermal patches. DPN is a neurological disorder caused ...

(WXYZ) — The U.S. Food and Drug Administration is warning consumers about the dangers of some topical pain relief products that have not been approved by the agency ...

Pain treatment involves usage of common analgesics or painkillers to reduce and treat body pain. Whenever, these analgesics are applied directly to the skin they are known as topical pain relief ...

BOSTON — Use of topical analgesics significantly improved pain scores in most patients with symptomatic hand and wrist osteoarthritis; however, according to researchers, the treatment is an ...

STATEN ISLAND, N.Y.-- The U.S Food and Drug Administration (FDA) is telling customers to avoid topical pain relief products from six companies. The products these companies make are usually marketed ...

Please provide your email address to receive an email when new articles are posted on . Tylenol Precise is made with lidocaine 4% and does not require a prescription. The product is made to appease 40 ...

Certain topical pain relief products could potentially lead to dangerous health effects, according to the U.S. Food and Drug Administration. In a warning issued by the agency on March 26, some ...

Use of a transdermal patch to deliver pain medication was found to be equivalent to medication delivered by an intravenous pump for controlling pain following surgery, according to a study in the ...

Compounded topical pain creams have gained popularity among some prescribers and patients, as they are marketed as having fewer side effects, lower likelihood for abuse, and the potential for greater ...

Topical Ketamir-2 significantly reduced both acute and inflammatory pain behaviors in animals, demonstrating rapid onset, durable effect, and comparable efficacy to injected morphine across both pain ...

The incidence of several types of chronic and acute pain will increase significantly over the next few years, driving growth in transdermal pain products to reach $9.2 billion in 2015, according to a ...